Navigation Links
Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
Date:11/15/2007

Unique Collaborative Meeting Includes Leading Scientists Investigating

Pregnancy and Breast Cancer Prevention

HOUSTON, Nov. 15 /PRNewswire/ -- Eighteen scientists investigating novel means for primary prevention of breast cancer by studying the natural impact of pregnancy on breast tissue met at Baylor College of Medicine in Houston on Monday, November 12, 2007 to share interim findings. All are part of the unique Avon Foundation Breast Cancer Prevention Research Initiative, one of many Avon Foundation-funded programs seeking new directions in breast cancer prevention, diagnosis, treatment and cure.

The meeting, convened by the Avon Foundation and Baylor College of Medicine, brought together a network of grant recipients who have been challenged through the Breast Cancer Prevention Research Initiative to use different approaches to address the question: what changes occur in a woman's breast tissue during pregnancy that alter her future risk of breast cancer. The goal is to identify the changes that reduce breast cancer risk and seek ways to provide the protective benefits to all women, regardless of reproductive history.

Pregnancy is associated with profound physiological changes in breast tissue and results in complex, age-dependent effects on breast cancer risk, with a transient increase in risk immediately following pregnancy, followed by long-lasting protection or risk, dependent upon age at first full-term pregnancy. Women who have their first full-term pregnancy before the age of 25 are at a decreased lifetime risk of breast cancer compared to women who never have children or who have a first pregnancy after the age of 35. Although the mechanisms that mediate pregnancy related changes in human breast tissue are poorly understood, it is hoped that a better understanding of these changes might lead to the development of innovative prevention strategies.

While specific interim data will not be released to the public because it is in the early stages, Dr. Marc Hurlbert, Scientific Director of the Avon Foundation, notes that, "we wish to bring the model of this program to the attention of the public and other researchers since collaborations and sharing of interim data is not a typical practice in research. The Avon Foundation hopes to be a change agent in the process of research as well as in the actual studies we fund."

A few of the areas of investigation in the Breast Cancer Prevention Research Initiative include:

-- New techniques to assess physiology and permeability in a woman's

breast under development by Dr. Dixie Mills, Clinical Research

Director, Dr. Susan Love Research Foundation. These techniques move

away from reliance on animal models and biopsy of specimens, and

instead study the physiology of the "living, intact breast."

-- Dr. Christine Erdmann, PhD, MPH, University of Michigan, School of

Public Health, reported her work analyzing epidemiology population data

from prior studies to understand the interactions of critical risk

factors, including age at first pregnancy, body mass index, and alcohol

consumption.

-- Several doctors provided very preliminary reports on their efforts to

understand which genes and proteins change after pregnancy in breast

tissue that could have a later impact on breast cancer.

"These are novel lines of research that will help in the fight to better understand and prevent breast cancer," said Dr. Daniel Medina, Professor, Department of Molecular & Cellular Biology, Baylor College of Medicine. "Baylor is proud to host this collaborative meeting with the Avon Foundation."

"The Breast Cancer Prevention Research Initiative is breaking traditional paradigms," noted Dr. Dixie Mills, "first, by providing funds to support these unusual research studies, and then by fostering collaboration. The Avon Foundation first hosted the grantees in New York in 2006 and now we are together again at Baylor. Twelve months into this multi-year initiative we are sharing data and discussing barriers to success. We will go back to our research after this meeting with fresh ideas and approaches to more rapidly advance our studies."

Attendees include representatives from Baylor College of Medicine, Dana- Farber Cancer Institute, Dr. Susan Love Research Foundation, Fred Hutchinson Cancer Research Center, Johns Hopkins University, Marin County Department of Health, Texas Tech University Health Sciences Center, University of Colorado Health Sciences Center, University of Illinois at Chicago, University of Kansas Medical Center, University of Massachusetts Amherst, University of Michigan, University of Michigan School of Public Health, University of Missouri, University of Nebraska Medical Center, University of Pennsylvania School of Medicine, and University of Wisconsin-Madison.

About the Avon Foundation and the Avon Walk for Breast Cancer Houston

The Avon Foundation is a 501(c)(3) public charity founded in 1955 to improve the lives of women and their families, with a mission now focused on breast cancer and domestic violence. Through 2007 Avon global philanthropy in 50 countries worldwide has raised and awarded more than $580 million, including $525 million raised by the Avon Breast Cancer Crusade to advance access to care and finding a cure. The major fundraising program is the Avon Walk for Breast Cancer series, and the first-ever Avon Walk Houston is slated for April 12-13, 2008. Baylor College of Medicine will be serving as the Medical Sponsor for the inaugural walk year in Houston. For more information: 866-505-AVON or visit http://www.avonfoundation.org.


'/>"/>
SOURCE Avon Foundation; Baylor College of Medicine
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Kevin McHale Instrumental in Forming the Help Me Hear Foundation
2. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
5. The Oral Cancer Foundation Urges HPV Vaccination for Males
6. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
7. Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
10. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 - ... Pump and Others)" published by P&S Market Research, the ... million in 2015, and it is expected to grow ... type, the insulin pump segment is expected to witness ...
(Date:5/25/2016)... SOUTHLAKE, Texas , May 25, 2016 /PRNewswire/ ... today the issuance to it by the US ...  9,218,608. The company,s technology includes proprietary processes for ... claims for health and wellness programs, HIPAA compliance ... "Our ...
(Date:5/25/2016)... ReportsnReports.com adds "Chronic Cough ... provides an overview on therapeutic pipeline of Chronic ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ... in the therapeutic development for Chronic Cough and ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... 26, 2016 , ... Georgia State University College of Law ... , Answering to the increasing demand for curricular specializations, the Certificate in Intellectual ... and land use law. ,  , “The demand for lawyers with specific knowledge ...
(Date:5/26/2016)... ... ... The Woodlands at John Knox Village , Florida’s first Life Plan ... and healing, celebrated its grand opening, today. The Woodlands at John Knox Village is ... Staff. , “This is an incredibly fulfilling time for John Knox Village as we ...
(Date:5/26/2016)... ... 26, 2016 , ... MadgeTech will be showcasing its line of data ... Hampshire at the MadgeTech headquarters. With products sold in more than 100 countries around ... including NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech ...
(Date:5/26/2016)... ... ... An April Gallup survey found rising health care costs to be the ... Senior Living (SHSL) may not share those same worries thanks to a new ... year, while holding the line on increasing their contributions, including premiums, deductibles and the ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... supply chain solutions, today announced the organization has earned its ISO 13485 certification, ... and is compliant with all rules and policies associated with ISO quality standard ...
Breaking Medicine News(10 mins):